IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,024,291 | +9693.6% | 1,693,782 | +4739.4% | 1.00% | +8250.0% |
| Q2 2023 | $663,950 | +22.3% | 35,000 | 0.0% | 0.01% | +20.0% |
| Q1 2023 | $542,850 | -66.3% | 35,000 | -81.1% | 0.01% | -44.4% |
| Q3 2021 | $1,609,000 | -17.8% | 185,200 | 0.0% | 0.02% | -30.8% |
| Q2 2021 | $1,957,000 | -59.7% | 185,200 | -38.8% | 0.03% | -75.0% |
| Q1 2021 | $4,855,000 | – | 302,700 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 1,500,000 | $26,625 | 8.85% |
| Deep Track Capital, LP | 9,710,000 | $172,352,500 | 7.24% |
| Logos Global Management LP | 3,150,000 | $55,912,500 | 6.55% |
| Ikarian Capital, LLC | 966,700 | $17,158,925 | 4.14% |
| COMMODORE CAPITAL LP | 1,150,505 | $20,421 | 3.08% |
| TCG Crossover Management, LLC | 854,853 | $15,173,641 | 2.68% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 519,614 | $9,223,149 | 2.64% |
| COWEN AND COMPANY, LLC | 1,250,000 | $22,187,500 | 2.32% |
| BVF INC/IL | 2,561,000 | $45,457,750 | 1.92% |
| Eventide Asset Management | 3,693,720 | $65,563,530 | 1.29% |